Gritstone Bio Q2 EPS $(0.16) Beats $(0.29) Estimate, Sales $921.00K Miss $1.44M Estimate
Author: Benzinga Newsdesk | August 13, 2024 04:29pm
Gritstone Bio (NASDAQ:
GRTS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 48.39 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $921.00 thousand which missed the analyst consensus estimate of $1.44 million by 35.82 percent. This is a 52.89 percent decrease over sales of $1.96 million the same period last year.
Posted In: GRTS